Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 419-426

  Jansen, Henning ^a   Loley, Christina ^b   Lieb, Wolfgang ^c   Pencina, Michael J ^d   Nelson, Christopher P ^f,g   Kathiresan, Sekar ^h,i   Peloso, Gina M ^h   Voight, Benjamin F ^j   Reilly, Muredach P ^j   Assimes, Themistocles L ^k   Boerwinkle, Eric ^l   Hengstenberg, Christian ^a   Laaksonen, Reijo ^m   McPherson, Ruth ⁿ   Roberts, Robert ⁿ   Thorsteinsdottir, Unnur ^o   Peters, Annette ^p,q   Gieger, Christian ^p,q   Rawal, Rajesh ^p,q   Thompson, John R ^r   König, Inke R ^b   Vasan, Ramachandran S ^e   Erdmann, Jeanette ^b   Samani, Nilesh J ^f,g   Schunkert, Heribert ^a   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g GLENFIELD HOSPITAL   (United Kingdom)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TEXAS   (United States)

^m TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁿ UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^o UNIVERSITY OF ICELAND   (Iceland)

^p INSTITUTE OF EPIDEMIOLOGY   (Germany)

^q Munich Heart Alliance   (Germany)

^r UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

Cardiovascular disease; Coronary artery disease; Genome wide association; SNP; Type 2 diabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PLEIOTROPY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; CASE CONTROL STUDY; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EUROPE; GENE FREQUENCY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; NORTH AMERICA; ODDS RATIO; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; DATABASES, GENETIC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NORTH AMERICA; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84936885307     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.033     Document Type: Article

References (49)

1. Franco O.H., Steyerberg E.W., Hu F.B., Mackenbach J., Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch. Intern Med. 2007, 11:1145-1151.
2. Rydén L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.-J., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2007, 1:88-136.
3. Preis S.R., Pencina M.J., Hwang S.-J., D'Agostino R.B., Savage P.J., et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009, 3:212-220.
4. Doerr R., Hoffmann U., Otter W., Heinemann L., Hunger-Battefeld W., Kulzer B., et al. Oral glucose tolerance test and HbAc for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 2011, 11:2923-2930.
5. DeFronzo R.A., Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 2011, 108:3B-24B.
6. Laakso M., Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann. Med. 1996, 5:415-418.
7. Nathan D.M., Cleary P.A., Backlund J.-Y.C., Genuth S.M., Lachin J.M., Orchard T.J., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N.Engl. J. Med. 2005, 25:2643-2653.
8. Lawlor D.A., Harbord R.M., Sterne J.A.C., Timpson N., Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 2008, 8:1133-1163.
9. Dupuis J., Langenberg C., Prokopenko I., Saxena R., Soranzo N., Jackson A.U., Wheeler E., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 2:105-116.
10. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 7:579-589.
11. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 5829:1336-1341.
12. Rung J., Cauchi S., Albrechtsen A., Shen L., Rocheleau G., Cavalcanti-Proença C., et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat. Genet. 2009, 10:1110-1115.
13. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 5:638-645.
14. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 2009, 1:18-24.
15. Willer C.J., Speliotes E.K., Loos R.J.F., Li S., Lindgren C.M., Heid I.M., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 1:25-34.
16. Morris A.P., Voight B.F., Teslovich T.M., Ferreira T., Segre A.V., Steinthorsdottir V., et al. Large scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 9:981-990. the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium.
17. Schunkert H., König I.R., Kathiresan S., Reilly M.P., Assimes T.L., Holm H., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 2011, 4:333-338.
18. Preuss M., König I.R., Thompson J.R., Erdmann J., Absher D., Assimes T.L., et al. Design of the Coronary ARtery DIsease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) Study: a Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ. Cardiovasc Genet. 2010, 5:475-483.
19. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I.W. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
20. Psaty B.M., O'Donnell C.J., Gudnason V., Lunetta K.L., Folsom A.R., Rotter J.I., et al. Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc Genet. 2009, 1:73-80. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
21. Assimes T.L., Knowles J.W., Basu A., Iribarren C., Southwick A., Tang H., et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum. Mol. Genet. 2008, 15:2320-2328.
22. Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., et al. Acommon variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 5830:1491-1493.
23. Winkelmann B.R., März W., Boehm B.O., Zotz R., Hager J., Hellstern P., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 1:S1-S73.
24. Kathiresan S., Voight B.F., Purcell S., Musunuru K., Ardissino D., Mannucci P.M., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 2009, 3:334-341.
25. Lehrke M., Millington S.C., Lefterova M., Cumaranatunge R.G., Szapary P., Wilensky R., et al. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J.Am. Coll. Cardiol. 2007, 4:442-449.
26. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., et al. Acommon allele on chromosome 9 associated with coronary heart disease. Science 2007, 5830:1488-1491.
27. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., Dixon R.J., et al. Genomewide association analysis of coronary artery disease. N.Engl. J. Med. 2007, 5:443-453.
28. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 7145:661-678.
29. Erdmann J., Willenborg C., Nahrstaedt J., Preuss M., König I.R., Baumert J., et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur. Heart J. 2011, 2:158-168.
30. Erdmann J., Grosshennig A., Braund P.S., König I.R., Hengstenberg C., Hall A.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 2009, 3:280-282.
31. Wichmann H.-E., Gieger C., Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005, 67:S26-S30.
32. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol. 1979, 3:281-290.
33. Dawber T.R., Kannel W.B., Revotskie N., Stokes J., Kagan A., Gordon T. Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am. J. Public Health Nations Health 1959, 49:1349-1356.
34. Splansky G.L., Corey D., Yang Q., Atwood L.D., Cupples L.A., Benjamin E.J., et al. The third generation cohort of the national heart, Lung, and blood Institute's Framingham heart study: design, recruitment, and initial examination. Am. J. Epidemiol. 2007, 11:1328-1335.
35. Ehret G.B., Munroe P.B., Rice K.M., Bochud M., Johnson A.D., Chasman D.I., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 7367:103-109. International Consortium for Blood Pressure Genome-Wide Association Studies.
36. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 6:743-753.
37. Pencina M.J., D'Agostino R.B., Larson M.G., Massaro J.M., Vasan R.S. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009, 24:3078-3084.
38. Grarup N., Sparsø T., Hansen T. Physiologic characterization of type 2 diabetes-related loci. Curr. Diab Rep. 2010, 6:485-497.
39. Deloukas P., Kanoni S., Willenborg C., Farrall M., Assimes T.L., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 2013, 1:25-33. CARDIoGRAMplusC4D Consortium.
40. Schunkert H., Erdmann J., Samani N.J. Genetics of myocardial infarction: a progress report. Eur. Heart J. 2010, 8:918-925.
41. McCarthy M.I. Genomics, type 2 diabetes, and obesity. N.Engl. J. Med. 2010, 24:2339-2350.
42. Pan W., Cedres L.B., Liu K., Dyer A., Schoen- berger J.A., Shekelle R.B., et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am. J. Epidemiol. 1986, 3:504-516.
43. Kleinman J.C., Donahue R.P., Harris M.I., Finucane F.F., Madans J.H., Brock D.B. Mortality among diabetics in a national sample. Am. J. Epidemiol. 1988, 2:389-401.
44. Folsom A.R., Szklo M., Stevens J., Liao F., Smith R., Eckfeldt J.H. Aprospective study of coronary heart disease in relation to fast- ing insulin, glucose, and diabetes: the Ath- erosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997, 6:935-942.
45. Fraser G.E., Strahan T.M., Sabaté J., Beeson W.L., Kissinger D. Effects of traditional coronary risk factors on rates of incident coronary events in a low-risk population: the Adventist Health Study. Circulation 1992, 2:406-413.
46. Voight B.F., Peloso G.M., Orho-Melander M., Frikke-Schmidt R., Barbalic M., Jensen M.K., et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012, 9841:572-580.
47. Lieb W., Jansen H., Loley C., Pencina M.J., Nelson C.P., Newton-Cheh C., et al. Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 2013, 5:995-1001.
48. Riddle M.C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010, 8:844-846.
49. Garner C. Upward bias in odds ratio estimates from genome-wide association studies. Genet. Epidemiol. 2007, 4:288-295.